SCHEMBL29640089

SCHEMBL29640089

CC(O)c1cccc(-n2ncc(-c3ccccc3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.39
NR4A2 P43354 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MYC P01106 1/20 0.38
WDR5 P61964 1/20 0.38
BRD4 O60885 1/20 0.37
BRD2 P25440 1/20 0.37
CREBBP Q92793 1/20 0.37
P2RX7 Q99572 2/20 0.37
CDK8 P49336 1/20 0.37
PHGDH O43175 1/20 0.36
PTPN5 P54829 1/20 0.35
COMT P21964 1/20 0.34
UGT2B7 P16662 1/20 0.34
PFKFB3 Q16875 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
RECQL P46063 1/20 0.33
ELOVL1 Q9BW60 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28741853 1.00 GRM5 (0.39) GRM5NR4A2KDM4EHSD17B10MYC
SCHEMBL5710307 0.82 GRM5 (0.48) GRM5KDM4EHSD17B10P2RX7
SCHEMBL28434913 0.79 RAB9A (0.48) GRM5KDM4EHSD17B10ADORA2AADORA1
SCHEMBL17279823 0.77 KDM4E (0.56) GRM5KDM4EHSD17B10P2RX7
SCHEMBL28741803 0.76 FYN (0.45) GRM5CDK8ADORA2AADORA1
SCHEMBL29626720 0.76 FYN (0.45) GRM5CDK8ADORA2AADORA1
SCHEMBL28278292 0.76 GABRA1 (0.45) GRM5KDM4EHSD17B10P2RX7
SCHEMBL22945301 0.75 CBLB (0.52)
SCHEMBL22945291 0.75 CBLB (0.52)
SCHEMBL28741797 0.75 CBLB (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-B Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2024-09-20 CN disclosed
CN-114450271-A Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2022-05-06 CN disclosed